ARMONK, N.Y., Feb. 25, 2026 /PRNewswire/ -- IBM (NYSE: IBM) today released the 2026 X-Force Threat Intelligence Index, revealing that cybercriminals are exploiting basic security gaps at dramatically higher rates, now accelerated by AI tools that help attackers identify weaknesses faster than ever. IBM XForce observed a 44% increase in attacks that began with the exploitation of public-facing applications, largely driven by missing authentication controls and AI-enabled vulnerability discovery. Some of the ...

Core Insights - HSBC Holdings reported a significant increase in fourth-quarter net profit, attributed to higher net interest income and one-off gains from disposals [1] Financial Performance - The net profit for the fourth quarter rose sharply, indicating strong financial performance [1] - The increase in net interest income played a crucial role in driving profitability [1] Business Strategy - The company is actively working on streamlining its businesses, which is part of its broader strategy to enhance operational efficiency [1]

Core Viewpoint - Abbott Cooper PLLC is investigating potential breaches of fiduciary duty by the Board of Directors of MarketWise, Inc. on behalf of the company's stockholders [1] Group 1 - The investigation focuses on whether the MarketWise Board of Directors has fulfilled its fiduciary obligations to stockholders, including its duty of loyalty [1]

分组1 - UFP Technologies reported quarterly earnings of $2.44 per share, exceeding the Zacks Consensus Estimate of $2.26 per share, with a year-over-year comparison showing a slight decrease from $2.46 per share [1] - The company achieved an earnings surprise of +7.81% for the quarter, following a previous surprise of +7.66% when it reported earnings of $2.39 per share against an expectation of $2.22 per share [1][2] - UFP's revenues for the quarter were $148.92 million, which fell short of the Zacks Consensus Estimate by 1.08%, but showed an increase from $144.07 million in the same quarter last year [2] 分组2 - The stock has gained approximately 8.9% since the beginning of the year, contrasting with a 0.1% decline in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is $2.55 on revenues of $156.63 million, and for the current fiscal year, it is $10.58 on revenues of $635.48 million [7] 分组3 - The Medical - Instruments industry, to which UFP belongs, is currently ranked in the top 29% of over 250 Zacks industries, indicating a favorable outlook [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5] - UFP currently holds a Zacks Rank of 3 (Hold), suggesting that the stock is expected to perform in line with the market in the near future [6]

Core Insights - Universal Insurance Holdings (UVE) reported quarterly earnings of $2.17 per share, exceeding the Zacks Consensus Estimate of $1.3 per share and significantly up from $0.25 per share a year ago, indicating strong performance [1] - The earnings surprise of +66.92% reflects the company's consistent ability to surpass consensus EPS estimates over the last four quarters [2] Financial Performance - The company achieved revenues of $407.93 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 9.37% and up from $384.81 million year-over-year [3] - Universal Insurance has also consistently exceeded consensus revenue estimates in the past four quarters [3] Stock Performance and Outlook - Despite the strong earnings report, Universal Insurance shares have declined approximately 10.6% since the beginning of the year, contrasting with the S&P 500's slight decline of 0.1% [4] - The company's future stock performance will largely depend on management's commentary during the earnings call and the subsequent earnings outlook [4][5] Earnings Estimates and Industry Context - Current consensus EPS estimate for the upcoming quarter is $1.32 on revenues of $370.25 million, while for the current fiscal year, it is $3.34 on revenues of $1.51 billion [8] - The Insurance - Property and Casualty industry is currently ranked in the top 32% of over 250 Zacks industries, suggesting a favorable environment for stock performance [9]

分组1 - Tigo Energy, Inc. reported a quarterly loss of $0.03 per share, better than the Zacks Consensus Estimate of a loss of $0.04, and a significant improvement from a loss of $0.44 per share a year ago, resulting in an earnings surprise of +18.26% [1] - The company posted revenues of $30.03 million for the quarter ended December 2025, slightly missing the Zacks Consensus Estimate by 0.32%, but showing a substantial increase from $17.27 million in the same quarter last year [2] - Tigo Energy has surpassed consensus EPS estimates in all four of the last quarters and has topped consensus revenue estimates three times during the same period [2] 分组2 - The stock has increased approximately 142.8% since the beginning of the year, contrasting with a slight decline of 0.1% in the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the next quarter is -$0.08 on revenues of $26.25 million, and for the current fiscal year, it is -$0.11 on revenues of $128.02 million [7] 分组3 - The Zacks Industry Rank indicates that the Solar industry is currently in the top 34% of over 250 Zacks industries, suggesting a favorable outlook for stocks within this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

分组1 - Zeta Global Holdings reported quarterly earnings of $0.28 per share, exceeding the Zacks Consensus Estimate of $0.23 per share, and showing an increase from $0.20 per share a year ago, resulting in an earnings surprise of +23.51% [1] - The company achieved revenues of $394.64 million for the quarter ended December 2025, surpassing the Zacks Consensus Estimate by 3.73%, and up from $314.67 million year-over-year [2] - Zeta has outperformed consensus revenue estimates four times over the last four quarters, while it has surpassed consensus EPS estimates two times [2] 分组2 - The stock has underperformed the market, losing about 26.4% since the beginning of the year, compared to a decline of 0.1% for the S&P 500 [3] - The company's earnings outlook is crucial for investors, as it includes current consensus earnings expectations for upcoming quarters and any recent changes to these expectations [4] - The current consensus EPS estimate for the coming quarter is $0.12 on revenues of $362.02 million, and for the current fiscal year, it is $0.99 on revenues of $1.73 billion [7] 分组3 - The Zacks Industry Rank indicates that the Technology Services sector is currently in the bottom 38% of over 250 Zacks industries, suggesting potential challenges for stocks in this sector [8] - Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors or through tools like the Zacks Rank [5][6]

Insider buying is one of the best bullish indicators out there, and this AI company has seen some serious activity recently.Insider buying is one of the best indicators of how a stock might perform in the future.The people running a company or who sit on its board of directors know it best. How could they not? They know things an investor couldn't, like sales figures since the last quarterly report or total intangibles you can't put on a spreadsheet, like office morale.It was once put very succinctly by inv ...

Core Insights - Globus Medical reported revenue of $826.42 million for the quarter ended December 2025, reflecting a year-over-year increase of 25.7% and surpassing the Zacks Consensus Estimate by 4.9% [1] - The company's EPS for the quarter was $1.28, up from $0.84 in the same quarter last year, resulting in an EPS surprise of 20.76% compared to the consensus estimate of $1.06 [1] Revenue Breakdown - International revenues reached $161.1 million, exceeding the average estimate of $147.72 million by analysts, marking a 19% increase year-over-year [4] - U.S. revenues totaled $665.32 million, surpassing the average estimate of $621.92 million, with a year-over-year growth of 27.5% [4] Product Category Performance - Net sales from Enabling Technologies were $55.62 million, exceeding the average estimate of $33.7 million, representing an 18.5% increase year-over-year [4] - Net sales from Musculoskeletal Solutions amounted to $770.8 million, above the average estimate of $735.95 million, showing a year-over-year growth of 26.3% [4] Stock Performance - Shares of Globus Medical have returned +0.5% over the past month, while the Zacks S&P 500 composite has decreased by -1%, indicating potential outperformance in the near term [3]

Core Insights - Evolent Health reported a revenue of $468.72 million for the quarter ended December 2025, reflecting a year-over-year decline of 27.5% [1] - The company's EPS for the same period was $0.08, compared to -$0.02 a year ago, indicating a positive turnaround [1] - The reported revenue was slightly below the Zacks Consensus Estimate of $469.22 million, resulting in a surprise of -0.11%, while the EPS exceeded expectations by 28% [1] Financial Performance - Evolent Health's shares have decreased by 25.3% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 1% [3] - The company currently holds a Zacks Rank of 3 (Hold), suggesting it may perform in line with the broader market in the near term [3] Key Metrics - Average PMPM Fees / Revenue per Case for Performance Suite was $13.87, slightly below the estimated $14.14 [4] - Average Lives on Platform for Cases reached 14 thousand, slightly above the estimated 13.86 thousand [4] - Total Revenue by product type for Performance Suite was $269.46 million, which is a 41% decline compared to the year-ago quarter [4] - Total Revenue by product type for Specialty Technology and Services Suite was $95.74 million, showing a year-over-year increase of 16.3% [4]